Cargando…

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update

Autologous hematopoietic stem cell transplantation (aHSCT) for autoimmune diseases has been applied for two decades as a treatment for refractory patients with progressive disease. The rationale behind aHSCT is that high-dose immunosuppression eliminates autoreactive T and B cells, thereby resetting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutter, Lisanne, Spierings, Julia, van Rhijn-Brouwer, Femke C. C., van Laar, Jacob M., van Wijk, Femke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920130/ https://www.ncbi.nlm.nih.gov/pubmed/29731752 http://dx.doi.org/10.3389/fimmu.2018.00767

Ejemplares similares

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation
por: Spierings, Julia, et al.
Publicado: (2020)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases
por: Mijnheer, Gerdien, et al.
Publicado: (2019)

Autologous stem cell transplantation in autoimmune arthritis restores immune homeostasis by renewal of the natural Treg compartment
por: van den Broek, T, et al.
Publicado: (2011)

Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint
por: Lutter, Lisanne, et al.
Publicado: (2022)

Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016)

Homeostatic Function and Inflammatory Activation of Ileal CD8(+) Tissue-Resident T Cells Is Dependent on Mucosal Location
por: Lutter, Lisanne, et al.
Publicado: (2021)

Review: Enhancers in Autoimmune Arthritis: Implications and Therapeutic Potential
por: Peeters, Janneke G. C., et al.
Publicado: (2017)

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3(int)CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies
por: Pouw, Juliëtte N., et al.
Publicado: (2022)

Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3(int)CD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies
por: Pouw, Juliëtte N., et al.
Publicado: (2023)

Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective
por: Spierings, Julia, et al.
Publicado: (2020)

PReS-FINAL-1006: Autologous bone marrow transplantation in autoimmune, experimental arthritis restores immune homeostasis by renewal of the natural tregs compartment
por: van den Broek, T, et al.
Publicado: (2013)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function
por: Van Wijk, Femke, et al.
Publicado: (2011)

Human Dendritic Cell Functional Specialization in Steady-State and Inflammation
por: Boltjes, Arjan, et al.
Publicado: (2014)

Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to Vaccines
por: Brinkman, D. M. C., et al.
Publicado: (2007)

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2018)

Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia
por: Gremmels, Hendrik, et al.
Publicado: (2019)

Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all
por: Spierings, J., et al.
Publicado: (2021)

Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
por: Jarduli‐Maciel, Luciana Ribeiro, et al.
Publicado: (2022)

Stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2008)

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Follicular Lymphoma
por: Cabrero, Mónica, et al.
Publicado: (2012)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Allogeneic stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2010)

Cell therapy for autoimmune diseases
por: Dazzi, Francesco, et al.
Publicado: (2007)

Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015)

Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model
por: van Rhijn-Brouwer, Femke Christina Ching-Chuan, et al.
Publicado: (2022)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
por: Broens, Bo, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Severe autoimmune pancytopenia after autologous hematopoietic stem cell transplantation for Hodgkin lymphoma
por: Fukui, Yuta, et al.
Publicado: (2022)

Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
por: van Laar, Jacob M
Publicado: (2000)

Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics
por: Massey, Jennifer C., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update
por: Mariottini, Alice, et al.
Publicado: (2023)

Tissue–Resident Memory T Cells in Chronic Inflammation—Local Cells with Systemic Effects?
por: Samat, Anoushka Ashok Kumar, et al.
Publicado: (2021)

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2018)

Editorial: Stem cell transplantation in autoimmune diseases (AID)
por: Schmalzing, Marc, et al.
Publicado: (2023)

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation
por: Mijnheer, Gerdien, et al.
Publicado: (2021)

Evaluation of bone marrow-derived cell-based therapies in the hindlimb ischaemia model: a protocol for a systematic review and meta-analysis
por: van Rhijn-Brouwer, Femke Christina Ching Chuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_plkiebhqre2c5mmm9lu0uu4k57